In CEP, it could be hypothesized that without the induction of ALAS2 expression, such as seen in FECH deficient patient, iron deficiency efficiently succeeds in inhibiting ALAS2 mRNA translation via the IRE/IRP system. The gene discussed is ALAS2; the disease is cutaneous porphyria.